Your session is about to expire
← Back to Search
Durvalumab + FLOT for Gastric Cancer
Study Summary
This trial is studying two different combinations of drugs as treatment for resectable gastric cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 867 Patients • NCT03084471Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are expected to live for at least 24 weeks.My organs and bone marrow are working well.I will have a major surgery to remove my cancer.My cancer is either adenosquamous, squamous cell, or a GI stromal tumor.I am fully active or restricted in physically strenuous activity but can do light work.My stomach cancer is operable and at least stage II.I have not received any treatment for my current cancer.I haven't taken immunosuppressive drugs in the last 14 days.I have received an organ transplant from another person.My cancer has spread to the lining of my abdomen or other distant parts.I am not allergic or intolerant to the drugs used in this study.
- Group 1: Arm B
- Group 2: Arm A
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other clinical trials have included FLOT chemotherapy?
"As of now, there are 336 clinical trials running for FLOT chemotherapy. 51 of those live clinical trials are in Phase 3. While the many studies for FLOT chemotherapy are based in Hat Yai, Texas, there are 12872 locations running studies for this treatment."
Does the age limit for participants in this research project fall below 70 years old?
"This trial is only for patients aged 18 to 200. If you are either under 18 or over 65, don't worry, there are still clinical trials for people in your age bracket. In fact, there are 7 trials for people under 18 and 485 for those over 65."
What are the ideal characteristics of participants in this research?
"955 participants who currently have esophagogastric junction and are between the ages of 18 and 200 are being recruited for this trial. In addition to meeting the age requirement, participants must also: have resectable disease (Stage II or higher per AJCC 8th edition), undergo radical surgery, have no prior anti-cancer therapy, have a WHO/ECOG performance status of 0 or 1, have adequate organ and marrow function, have a tumor sample available, have a life expectancy of at least 24 weeks."
What is the U.S. government's stance on FLOT chemotherapy?
"FLOT chemotherapy has gone through multiple Phase 3 trials, so there is a fair amount of data attesting to its efficacy and safety."
What conditions respond well to FLOT chemotherapy?
"FLOT chemotherapy can offer hope to patients that have unresectable stage iii non-small cell lung cancer that is previously untreated or metastatic ureter urothelial carcinoma."
Are we still looking for people to enroll in this research project?
"Unfortunately, this study is not presently looking for participants, however, it was first posted on 11/17/2020. Although this study isn't currently active, there are many other trials (487 to be precise) that are seeking patients right now."
Share this study with friends
Copy Link
Messenger